Spire (US) launches Spi-Polymer surface treatment:
This article was originally published in Clinica
Spire (US) has developed the Spi-Polymer process which reduces biofouling on the surface of polymeric components of IVD assay devices. The surface treatment is applied to devices using ion implantation technology, providing a more hydrophilic surface which reduces blood cell, air bubble and plasma protein adherence. The reduction of biofouling improves accuracy for diagnostic assay systems by enhancing flow performance and reducing maintenance, says Spire.